In this paper, a novel image processing strategy is detailed for simultaneous measurement of tumor perfusion and neovascular morphology parameters from a sequence of dynamic contrast-enhanced ultrasound (DCE-US) images. After normalization and tumor segmentation, a global time-intensity curve describing contrast agent flow was analyzed to derive surrogate measures of tumor perfusion (i.e., peak intensity, time-to-peak intensity, area under the curve, wash-in rate, and wash-out rate). Further, a maximum intensity image was generated from these same segmented image sequences and each vascular component was skeletonized via a thinning algorithm. This skeletonized dataset and collection of vessel segments were then investigated to extract parameters related to the neovascular network and physical architecture (i.e., vessel-to-tissue ratio, number of bifurcations, vessel count, and average vessel length and tortuosity). An efficient computation of local perfusion parameters is also introduced and operates by averaging time-intensity curve data over each individual neovascular segment. Each skeletonized neovascular segment is then color-coded by these local measures to produce a parametric map detailing spatial properties of tumor perfusion. Longitudinal DCE-US image datasets were collected in 6 patients diagnosed with invasive breast cancer using a Philips iU22 ultrasound (US) system equipped with a L9-3 MHz transducer and Definity contrast agent. Patients were imaged using US before and after contrast agent dosing at baseline and again at weeks 6, 12, 18, and 24 after treatment started. Preliminary clinical results suggest that breast tumor response to neoadjuvant chemotherapy may be associated with temporal and spatial changes in DCE-US derived parametric measures of tumor perfusion. Moreover, changes in neovascular morphology parametric measures may also help identify any breast tumor response (or lack thereof) to systemic treatment. Breast cancer management from early detection to therapeutic monitoring is currently undergoing profound changes. The development of novel imaging techniques that are sensitive to the unique biological conditions of each individual tumor represent valuable tools in the pursuit of personalized medicine.